German biotech firm CureVac AG has agreed to an alliance with drugmaker Bayer AG to help it seek regulatory approval for its experimental COVID-19 vaccine and distribute doses, the two companies said yesterday.
“Bayer will contribute its expertise and established infrastructure in areas such as clinical operations, regulatory affairs, pharmacovigilance, medical information, supply chain performance as well as support in selected countries,” they said.
Financial terms were not disclosed.
Photo: Reuters
CureVac, which had said it was looking for a larger partner, last month started a late-stage clinical trial of its COVID-19 vaccine candidate, banking on the same technology that has allowed rivals BioNTech and Moderna to lead the development race.
The tie-up echoes a similar deal by German peer BioNTech SE, also a research-focused biotech firm, which last year agreed to collaborate with global pharma giant Pfizer Inc on its vaccine, which is now being rolled out globally.
CureVac, which is listed on the NASDAQ, and backed by investors Dietmar Hopp, the Gates Foundation, GlaxoSmithKline PLC and the German government, has said that it aims to produce up to 300 million doses of the vaccine this year and up to 600 million next year.
In March last year, CureVac was at the center of a row over alleged attempts by US President Donald Trump to gain access to the vaccine, but the company denied at the time having received any US offers for the company or its assets.
As it awaits regulatory approval, the EU has secured up to 405 million doses of the immunization, among a slew of supply deals agreed between the bloc and other vaccine developers.
Bayer’s pharma unit, which is trying to build a new cell and gene therapy business, has expertise in cancer, hemophilia, multiple sclerosis, cardiovascular diseases and women’s health, but not in vaccines.
The group’s stock has been battered by writedowns at its agriculture division, litigation woes and a bleaker profit outlook, in large part related to its US$63 billion takeover of seed maker Monsanto Co.
The Eurovision Song Contest has seen a surge in punter interest at the bookmakers, becoming a major betting event, experts said ahead of last night’s giant glamfest in Basel. “Eurovision has quietly become one of the biggest betting events of the year,” said Tomi Huttunen, senior manager of the Online Computer Finland (OCS) betting and casino platform. Betting sites have long been used to gauge which way voters might be leaning ahead of the world’s biggest televised live music event. However, bookmakers highlight a huge increase in engagement in recent years — and this year in particular. “We’ve already passed 2023’s total activity and
Nvidia Corp CEO Jensen Huang (黃仁勳) today announced that his company has selected "Beitou Shilin" in Taipei for its new Taiwan office, called Nvidia Constellation, putting an end to months of speculation. Industry sources have said that the tech giant has been eyeing the Beitou Shilin Science Park as the site of its new overseas headquarters, and speculated that the new headquarters would be built on two plots of land designated as "T17" and "T18," which span 3.89 hectares in the park. "I think it's time for us to reveal one of the largest products we've ever built," Huang said near the
China yesterday announced anti-dumping duties as high as 74.9 percent on imports of polyoxymethylene (POM) copolymers, a type of engineering plastic, from Taiwan, the US, the EU and Japan. The Chinese Ministry of Commerce’s findings conclude a probe launched in May last year, shortly after the US sharply increased tariffs on Chinese electric vehicles, computer chips and other imports. POM copolymers can partially replace metals such as copper and zinc, and have various applications, including in auto parts, electronics and medical equipment, the Chinese ministry has said. In January, it said initial investigations had determined that dumping was taking place, and implemented preliminary
Intel Corp yesterday reinforced its determination to strengthen its partnerships with Taiwan’s ecosystem partners including original-electronic-manufacturing (OEM) companies such as Hon Hai Precision Industry Co (鴻海精密) and chipmaker United Microelectronics Corp (UMC, 聯電). “Tonight marks a new beginning. We renew our new partnership with Taiwan ecosystem,” Intel new chief executive officer Tan Lip-bu (陳立武) said at a dinner with representatives from the company’s local partners, celebrating the 40th anniversary of the US chip giant’s presence in Taiwan. Tan took the reins at Intel six weeks ago aiming to reform the chipmaker and revive its past glory. This is the first time Tan
RSS